Hubei Xunda Pharmaceutical
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Hubei Xunda Pharmaceutical - overview
Established
2002
Location
Wuxue, Hubei, China
Primary Industry
Pharmaceuticals
About
Hubei Xunda Pharmaceutical operates as a producer of anti-inflammation and pain easing drugs in China. The firm's main product is ketoprofen.
Current Investors
Shenzhen Capital Real Estate Fund
Primary Industry
Pharmaceuticals
Sub Industries
Dermatology, Pharmaceuticals
Website
www.xundapharm.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.